Epidemiology - Pharmacoepidemiology

Overview

The Epidemiology - Pharmacoepidemiology Option of the Ph.D. Program at the McGill University may be of interest to students from the natural or quantitative sciences (e.g., microbiology, computer science, biostatistics, statistics, economics), Public or Population Health, or Epidemiology, or hold a degree in one of the health professional sciences (e.g., medicine, pharmacy). 

The programme

Applicants must have an interest in the epidemiology of medications, along with strong conceptual, analytic, and quantitative skills (including differential and integral calculus) at the undergraduate level.

The Pharmacoepidemiology Option prepares students with the advanced epidemiological research skills needed to undertake original contributions to new knowledge related to pharmacoepidemiology. 

The program is generally completed in four to five years. In addition to obtaining advanced training in the foundations and principles of epidemiology and applied biostatistics as part of the Ph.D. program, students in the Pharmacoepidemiology Option receive specialized training in pharmacoepidemiology, including advanced pharmacoepidemiologic methods, pharmacology for pharmacoepidemiologists, and practical experience in pharmacoepidemiology through their doctoral thesis.

Graduates will be prepared to engage in scientific collaboration, and communicate results to other scientists and diverse audiences. They will go on to careers in pharmacoepidemiology in public, private, and academic settings. With a world-renowned reputation for excellence in pharmacoepidemiology, McGill-trained pharmacoepidemiologists are known for methodological and quantitative rigour, and quantitative analytic independence.